Cargando…
The Vexing Voyage of Vasopressin: The Consequences of Granting Market Exclusivity to Unapproved Drugs
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353103/ https://www.ncbi.nlm.nih.gov/pubmed/35940656 http://dx.doi.org/10.1016/j.chest.2022.02.048 |
| _version_ | 1784762801609244672 |
|---|---|
| author | Bendicksen, Liam Kesselheim, Aaron S. Rome, Benjamin N. |
| author_facet | Bendicksen, Liam Kesselheim, Aaron S. Rome, Benjamin N. |
| author_sort | Bendicksen, Liam |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9353103 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American College of Chest Physicians. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93531032022-08-05 The Vexing Voyage of Vasopressin: The Consequences of Granting Market Exclusivity to Unapproved Drugs Bendicksen, Liam Kesselheim, Aaron S. Rome, Benjamin N. Chest Humanities: Exhalations American College of Chest Physicians. Published by Elsevier Inc. 2022-08 2022-08-05 /pmc/articles/PMC9353103/ /pubmed/35940656 http://dx.doi.org/10.1016/j.chest.2022.02.048 Text en © 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Humanities: Exhalations Bendicksen, Liam Kesselheim, Aaron S. Rome, Benjamin N. The Vexing Voyage of Vasopressin: The Consequences of Granting Market Exclusivity to Unapproved Drugs |
| title | The Vexing Voyage of Vasopressin: The Consequences of Granting Market Exclusivity to Unapproved Drugs |
| title_full | The Vexing Voyage of Vasopressin: The Consequences of Granting Market Exclusivity to Unapproved Drugs |
| title_fullStr | The Vexing Voyage of Vasopressin: The Consequences of Granting Market Exclusivity to Unapproved Drugs |
| title_full_unstemmed | The Vexing Voyage of Vasopressin: The Consequences of Granting Market Exclusivity to Unapproved Drugs |
| title_short | The Vexing Voyage of Vasopressin: The Consequences of Granting Market Exclusivity to Unapproved Drugs |
| title_sort | vexing voyage of vasopressin: the consequences of granting market exclusivity to unapproved drugs |
| topic | Humanities: Exhalations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353103/ https://www.ncbi.nlm.nih.gov/pubmed/35940656 http://dx.doi.org/10.1016/j.chest.2022.02.048 |
| work_keys_str_mv | AT bendicksenliam thevexingvoyageofvasopressintheconsequencesofgrantingmarketexclusivitytounapproveddrugs AT kesselheimaarons thevexingvoyageofvasopressintheconsequencesofgrantingmarketexclusivitytounapproveddrugs AT romebenjaminn thevexingvoyageofvasopressintheconsequencesofgrantingmarketexclusivitytounapproveddrugs AT bendicksenliam vexingvoyageofvasopressintheconsequencesofgrantingmarketexclusivitytounapproveddrugs AT kesselheimaarons vexingvoyageofvasopressintheconsequencesofgrantingmarketexclusivitytounapproveddrugs AT romebenjaminn vexingvoyageofvasopressintheconsequencesofgrantingmarketexclusivitytounapproveddrugs |